Products for Research Use Only
RegisterLogin

RIPK1-IN-35

CAT: 0804-HY-178762SSize: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-178762SSize:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
RIPK1-IN-35 is a selective and orally active RIPK1 inhibitor with an IC50 of 5.33 nM. RIPK1-IN-35 has a potent protective effect against necroptosis in both human and murine cells. RIPK1-IN-35 shows good therapeutic effects in both TNF-α-induced systemic inflammatory response syndrome and DSS -induced inflammatory bowel disease models. RIPK1-IN-35 can be used to the study of inflammatory diseases related to necroptosis[1].
UNSPSC
12352005
Target
Necroptosis; RIP kinase
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C(NC1=NNC(C2=CC=C3N(CCOC3=C2)C(CC4=C(C=CC(OC(F)F)=C4)F)=O)=C1)C5=NN(C([2H])([2H])[2H])C(C=C5)=O
Molecular Formula
C26H18D3F3N6O5
Molecular Weight
557.50
References & Citations
[1]Tao Q, et al. Discovery of a 1H-Pyrazol-3-Amine Derivative as a Novel, Selective, and Orally Available RIPK1 Inhibitor for the Treatment of Inflammatory Disease. J Med Chem. 2025 Oct 23;68 (20) :21766-21785.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RIPK1

Related Products

CatalogName
HY-179235RIPK1-IN-37
HY-162097RIPK1-IN-20
HY-126296RIPK1-IN-3
HY-169107RIPK1-IN-25
HY-179680RIPK1-IN-38
HY-175007RIPK1-IN-32
HY-156367RIPK1-IN-16
HY-146758RIPK1-IN-14
HY-144277RIPK1-IN-12
HY-173574RIPK1-IN-31

Alternative Products

CatalogName
574852-01RIPK1
M33106-01RIPK1-IN-4
ASD98244-01RIPK1-IN-7
T211437-01RIPK1-IN-32
T208885-01RIPK1-IN-20
T204483-01RIPK1-IN-28
T200682-01RIPK1-IN-24
T62762-01RIPK1-IN-11
T60862-01RIPK1-IN-15
T62723-01RIPK1-IN-12

Popular Products